Rest tremor (RT) in Parkinson’s disease has been reported to correlate positively with ipsilateral striatal dopamine transporter (DAT) binding. This study tested two alternative explanations for that observation: (1) a tremor-specific ipsilateral pathophysiologic mechanism linking tremor amplitude to local dopaminergic function, or (2) a more parsimonious explanation that patients with RT have globally better-preserved dopaminergic terminals, producing an apparent ipsilateral correlation.
The authors aimed to distinguish severity-dependent, symptom-specific associations from group-level differences in dopaminergic degeneration.
Analyses used two cross-sectional samples drawn from the Parkinson's Progression Markers Initiative (PPMI). The baseline sample included N=1055 participants. A follow-up sample with a median 2.2-year interval included N=652 participants. The dataset used was obtained from the PPMI database on August 2, 2026. The report is a preprint on medRxiv and has not completed peer review.
Clinical motor signs examined were rest tremor, bradykinesia, and rigidity. Imaging measures were striatal DAT binding values, evaluated both ipsilateral and contralateral to the clinically assessed motor signs. The analysis therefore compared lateralized correlations between motor severity and striatal binding.
To separate effects attributable to overall group differences from severity-dependent associations, the authors applied permutation testing that shuffled severity scores. This approach generated a null distribution reflecting associations expected under the absence of symptom-specific severity effects but preserving group-level structure.
In addition, out-of-sample prediction was used to evaluate how well striatal binding could predict symptom presence (classification) versus symptom severity (continuous prediction). Predictive performance metrics reported include area under the receiver operating characteristic curve (AUC) for presence and R2 for explained variance in severity.
Both bradykinesia and rigidity demonstrated large, expected contralateral correlations with striatal DAT binding. These contralateral correlations were consistently distinguishable from the permutation null in every comparison. In predictive analyses, striatal binding for these signs predicted both the presence of the symptom and its severity, consistent with a dose-dependent relationship between dopaminergic loss and these cardinal parkinsonian motor features.
By contrast with bradykinesia and rigidity, RT's ipsilateral correlation with striatal binding was generally not distinguishable from the permutation null in most comparisons. When tested as a predictor, striatal binding—whether ipsilateral or contralateral—showed only modest ability to discriminate presence of RT (AUC range 0.55–0.61) and did not predict tremor severity (R2 < 0.002) in either cohort. These results indicate that while striatal binding can weakly classify whether RT is present, it does not explain graded differences in tremor amplitude.
The pattern of findings argues against a direct, graded pathophysiologic link between tremor amplitude and ipsilateral dopaminergic function. Instead, the authors interpret the ipsilateral binding–RT correlation reported in prior studies as likely reflecting a broader difference in degeneration patterns among patients who present with RT. In other words, patients with RT may, as a group, have relatively better-preserved dopamine terminals, producing the observed ipsilateral correlation, rather than tremor amplitude being determined in a dose-dependent manner by ipsilateral DAT binding.
This interpretation aligns with the contrast between the clear, contralateral, severity-linked associations seen for bradykinesia and rigidity and the weak, presence-only association for RT.
The report is a medRxiv preprint and has not been peer reviewed; the authors note standard declarations about ethical approvals and consent. The study uses cross-sectional and follow-up PPMI data; details beyond cohort sizes and median follow-up reported here (baseline N=1055; follow-up N=652; median 2.2 years) were not expanded in the abstract. Data used are available from the PPMI database (RRID:SCR_006431), with the extraction date reported as August 2, 2026.
Competing interests declared by one author include received payments and consultancy relationships; these are reported in the source. The authors’ overall conclusion recommends against positing a direct tremor-amplitude–ipsilateral-DAT mechanism and favors a model in which ipsilateral binding–RT correlations reflect group-level differences in dopaminergic degeneration.